Method for synthesizing chiral dihydro-5H-pyrrolo[2,1-c][1,4]-benzodiazepino-5-one
A technology of benzodiazepines and dihydropyrrole, applied in the synthesis of chiral dihydro-5H-pyrrolo[2,1-c][1,4]-benzodiazepine-5-one field, to achieve the effect of simple and practical reaction operation, convenient preparation, high reactivity and enantioselectivity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0036] Embodiment 1: optimization of conditions
[0037]In a nitrogen-filled glove box, (1,5-cyclooctadiene) iridium chloride dimer (0.0025 mmol, 1.7 mg) and one of the chiral ligands in the following formula (0.0055 mmol ) into a reaction flask with 1 mL of mixed solvent (the volume ratio of dichloromethane and toluene is 1:2), stirred at room temperature for 10 minutes, and then transferred the prepared catalyst to another container containing the raw material pyrrolo[2,1 -c] [1,4]-benzodiazepin-5-one 1a (38 mg, 0.125 mmol) and morpholine trifluoroacetate (2.5 mg, 0.0125 mmol) in a reaction vial, shared 3mL of mixed solvent (the volume ratio of dichloromethane and toluene is 1:2). The reaction bottle was placed in a stainless steel autoclave, and hydrogen gas was introduced at a pressure of 50 atmospheres, and the reaction was carried out at room temperature for 24 hours. Slowly release hydrogen, remove the solvent with a rotary evaporator, and then directly column chromat...
Embodiment 2
[0043] Example 2: Synthesis of various chiral dihydro-5H-pyrrolo[2,1-c][1,4]-benzodiazepine-5-ones by iridium-catalyzed asymmetric hydrogenation 2
[0044] In a nitrogen-filled glove box, (1,5-cyclooctadiene) iridium chloride dimer (0.0025 mmol, 1.7 mg) and chiral ligand (S, S, R)-C 3 *-TunePhos (0.0055 mmol) in the reaction bottle, add 1mL mixed solvent (the volume ratio of methylene chloride and toluene is 1: 2), stir at room temperature for 10 minutes, then transfer the prepared catalyst to another container containing The substrate pyrrolo[2,1-c][1,4]-benzodiazepin-5-one 1 (0.125 mmol) and morpholine trifluoroacetate (2.5 mg, 0.0125 mmol) In the reaction flask, 3 mL of mixed solvent (the volume ratio of dichloromethane and toluene is 1:2) is shared. The reaction bottle was placed in a stainless steel autoclave, and hydrogen gas was introduced at a pressure of 50 atmospheres, and the reaction was carried out at room temperature for 24 hours. Slowly release hydrogen, remov...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com

![Method for synthesizing chiral dihydro-5H-pyrrolo[2,1-c][1,4]-benzodiazepino-5-one](https://images-eureka-patsnap-com.sutd.idm.oclc.org/patent_img/8721003a-0f8e-4840-b620-3c6dcd1a65ad/FDA0000138253650000011.png)
![Method for synthesizing chiral dihydro-5H-pyrrolo[2,1-c][1,4]-benzodiazepino-5-one](https://images-eureka-patsnap-com.sutd.idm.oclc.org/patent_img/8721003a-0f8e-4840-b620-3c6dcd1a65ad/BDA0000138253660000021.png)
![Method for synthesizing chiral dihydro-5H-pyrrolo[2,1-c][1,4]-benzodiazepino-5-one](https://images-eureka-patsnap-com.sutd.idm.oclc.org/patent_img/8721003a-0f8e-4840-b620-3c6dcd1a65ad/BDA0000138253660000051.png)